On Monday, the FDA authorized the first-ever oral GLP-1 pill for obesity, developed by Novo Nordisk, the company behind the popular weight loss injection, Wegovy. This groundbreaking decision is ...

CagriSema would be the first combo GLP-1 if it’s approved, while orforglipron would be the first GLP-1 pill approved for ...

In what the authors are hailing as a “game-changer” in the realm of weight loss therapy, a major global study has demonstrated how an obesity drug can cut significant body weight from many of those ...

A new category of expensive weight loss drugs has exploded in popularity over the past few months as celebrities, tech moguls and social media stars have testified that they’ve been able to rapidly ...

Dr. Deborah Horn wants to give her patients with obesity the best possible care. But too often, the conversation in appointments isn't focused on picking the best treatment options, which sometimes ...

Investing.com -- The global obesity epidemic represents one of the most pressing public health challenges of our time. With nearly three-quarters of the U.S. population categorized as overweight or ...

Please provide your email address to receive an email when new articles are posted on . A new generation of obesity drugs is changing the treatment landscape for patients and providers, with options ...

A new weight-loss shot is being hailed as a “game changer” — with the potential to cut diabetes risk by 50% and “fight obesity as a disease” for the first time, according to a new study. The research, ...

Obesity doesn't discriminate - every age, ethnic group and education level is affected. Many people blame the nation's farm policy for its weight problem. Some believe doling out farm subsidies based ...

For years, everyone has been pointing blame in every which direction on what is the single most cause of obesity in children. Most of the time the finger pointing ends up being pointed at soft drink ...

The CDC says 42.4% of all adults in the United States suffer from obesity. A new weight-loss treatment is being heralded by some health experts as "groundbreaking," and a potential "game changer" in ...